Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Available × talazoparib × Genitourinary × Clear all

Status

Recruiting 5 Completed 5 Active not recruiting 2 Unknown 1 Terminated 1 Suspended 1 Available 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1 Neoplasm Metastasis 1

Interventions

ulixertinib 1 tempol 1 talazoparib 1 dodecyl maltoside 1 balstilimab 1 TEMPOL-H 1 Proton Pump Inhibitors 1 Mitomycin 1 Hydrocortisone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05650476 2025-06-12

Pre-approval Single-patient Expanded Access for Talazoparib (PF-06944076)

Pfizer

Neoplasm Metastasis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡